XSES
A50
Market cap993mUSD
Oct 30, Last price
0.05SGD
1D
2.13%
1Q
-9.43%
Jan 2017
-52.94%
IPO
-77.78%
Name
Thomson Medical Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
Key people
Wee Kiat Lim
Executive Vice Chairman of the Board · since 2022
Lakshmi Devi
Chief Executive Officer - TMC Fertility Holdings Sdn Bhd · since 2024
Jean- Marcel Guillon
Chief Executive Officer - Far East Medical Vietnam Limited · since 2024
Suen Ming Lee
Chief Executive Officer - Thomson Medical Singapore · since 2023
Mor Ng
Chief Operating Officer · since 2024
Zing Yuen Tan
Chief Risk and Compliance Officer · since 2021
Jun Li Heng
Group Chief Executive Officer, Executive Director · since 2022
Group Chief Financial Officer, Executive Director · since 2019
Le Quyen Tran
Chief Financial Officer - Far East Medical Vietnam Limited · since 2024
Group Chief Financial Officer - TMC Life Sciences Berhad · since 2024
Soon Soo Foo
Joint Company Secretary · since 2018
Sin Yuen Seah
Company Secretary · since 2025
Ser Miang Ng
Non-Executive and Non-Independent Chairman of the Board · since 2025
Kooi Ong Tong
Independent Non-Executive Chairman of the Board · since 2026
Lai Ling Leong
Non-Executive Independent Director · since 2022
Pang Liang Ong
Non-Independent and Non-Executive Director · since 2025
Non-Executive Independent Director · since 2022
Legal address
101 Thomson Road
#20-04/05
United Square
Singapore, 01 307591
SG
#20-04/05
United Square
Singapore, 01 307591
SG
Headquarters
101 Thomson Road
#20-04/05
United Square
Singapore 307591
SG
#20-04/05
United Square
Singapore 307591
SG
Previous name
ROWSLEY LTD.
Previous name
ASPNETCENTRE LTD
Previous name
ASP HOLDINGS PTE LTD
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||